2 Background: Microarray genome analysis is realising its promise for improving detection of genetic abnormalities in individuals with mental retardation (MR) and congenital abnormality. Copy number variations (CNVs) are now readily detectable using a variety of platforms and a major challenge is the distinction of pathogenic from ubiquitous, benign polymorphic CNVs. The aim of this study was to investigate replacement of time-consuming, locus-specific testing for specific microdeletion and microduplication syndromes with microarray analysis, which theoretically should detect all known syndromes with CNV etiologies as well as new ones
Chromosomal Microarray Analysis (CMA) is currently considered to be the first-tier clinical test for...
Genome-wide analysis of DNA copy-number changes using microarray-based technologies has enabled the ...
International audienceArray-CGH has revealed a large number of copy number variations (CNVs) in pati...
BACKGROUND: Microarray genome analysis is realising its promise for improving detection of genetic a...
Genomic microarrays have been implemented in the diagnosis of patients with unexplained mental retar...
Contains fulltext : 80578.pdf (publisher's version ) (Closed access)Microarray-bas...
Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity usi...
Background: Genomic deletions and duplications are important in the pathogenesis of...
Microarray analysis has provided significant advances in the diagnosis of conditions resulting from ...
Abstract Background Chromosomal microarray analysis (CMA) is recommended as the first-tier clinical ...
Submicroscopic chromosomal copy number variations (CNVs), such as deletions and duplications, accoun...
Genomic microarray analysis is rapidly replacing conventional chromosome analysis by molecular karyo...
The cause of mental retardation in one-third to one-half of all affected individuals is unknown. Mic...
Item does not contain fulltextGenome-wide analysis of DNA copy-number changes using microarray-based...
PubMed ID: 25059023New array technologies have facilitated the analysis of submicroscopic chromosoma...
Chromosomal Microarray Analysis (CMA) is currently considered to be the first-tier clinical test for...
Genome-wide analysis of DNA copy-number changes using microarray-based technologies has enabled the ...
International audienceArray-CGH has revealed a large number of copy number variations (CNVs) in pati...
BACKGROUND: Microarray genome analysis is realising its promise for improving detection of genetic a...
Genomic microarrays have been implemented in the diagnosis of patients with unexplained mental retar...
Contains fulltext : 80578.pdf (publisher's version ) (Closed access)Microarray-bas...
Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity usi...
Background: Genomic deletions and duplications are important in the pathogenesis of...
Microarray analysis has provided significant advances in the diagnosis of conditions resulting from ...
Abstract Background Chromosomal microarray analysis (CMA) is recommended as the first-tier clinical ...
Submicroscopic chromosomal copy number variations (CNVs), such as deletions and duplications, accoun...
Genomic microarray analysis is rapidly replacing conventional chromosome analysis by molecular karyo...
The cause of mental retardation in one-third to one-half of all affected individuals is unknown. Mic...
Item does not contain fulltextGenome-wide analysis of DNA copy-number changes using microarray-based...
PubMed ID: 25059023New array technologies have facilitated the analysis of submicroscopic chromosoma...
Chromosomal Microarray Analysis (CMA) is currently considered to be the first-tier clinical test for...
Genome-wide analysis of DNA copy-number changes using microarray-based technologies has enabled the ...
International audienceArray-CGH has revealed a large number of copy number variations (CNVs) in pati...